Grant is the protocol chair for the Pre-Exposure Prophylaxis Initiative (iPrEx) trial, (1) the first placebo-controlled trial to demonstrate partial protection from HIV infection with oral preexposure prophylaxis (PrEP).
What does PreEP stand for?
PreEP stands for Pre-Exposure Prophylaxis (rabies immunization)
This definition appears rarely and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Program for Research and Development of Ogoni (Nigeria)
- Parks and Recreation/Environmental Education (Slippery Rock University; Pennsylvania)
- Partial Reinforcement Extinction Effect (reinforced behavior)
- Population Resources and Environment Economics (Renmin University; China)
- Predicted Resting Energy Expenditure
- Preliminary Regulatory Economic Evaluation
- Professional Residency in Environmental Education (training program; Teton Science School; Wyoming)
- Position-Resolved Electron Energy Loss Spectroscopy
- Premature Child
- Pacific Rim Energy and Environment Network
- Pacific Renewable Energy Fund (Micronesia)
- Paris Real Estate Finders (Paris, France)
- Polish Real Estate Federation (est. 1995)
- Pooled Real Estate Fund
- Priest River Experimental Forest (Rocky Mountain Research Station; Moscow, ID)
- Pulse Repetition Frequency
- Prepare Final Acceptance Trial
- Prudential Real Estate Fixed Income Investors (mortgage investment manager; Prudential Financial, Inc.; Newark, NJ)
Samples in periodicals archive:
To do this, the individual must be tested and prove to be HIV negative prior to starting on pre-exposure prophylaxis.
Other important interventions include medical male circumcision, which offers a highly effective and durable way to protect heterosexual men from HIV infection; and potentially, pre-exposure prophylaxis with antiretroviral medications, which have shown promise in reducing an individual's risk of acquiring HIV infection.
The guidance is based on clinical trials indicating that HIV-negative people taking a daily dose of oral antiretroviral medication, known as pre-exposure prophylaxis (PrEP), to reduce the risk of infection, is both safe for people to use and effective in preventing HIV.
The number of people eligible for antiretroviral treatment (ART) will grow by around 6 million as a result of recent World Health Organization (WHO) recommendations on the use of antiretroviral drugs to prevent HIV transmission, Dr Gottfried Hirnschall, head of the WHO's HIV department told the IAPAC Controlling the HIV Pandemic with Antiretrovirals: Treatment as Prevention and Pre-Exposure Prophylaxis Evidence Summit in London.
The study had enrolled 5,029 sexually active, HIV-negative women to test the daily use of two different oral antiretrovirals as pre-exposure prophylaxis (PREP): tenofovir and a combination tablet containing emtricitabine and tenofovir (known by the trademark Truvada), and a vaginal gel containing 1% tenofovir.
Julio Montaner said July 14 that pre-exposure prophylaxis should be used worldwide in order to derail the AIDS epidemic after two HIV studies in Africa revealed that antiretroviral drugs used in combination with anti-retroviral therapy helps treat HIV and prevents transmission through decreasing contagiousness.